Business Description
Edwards Lifesciences Corp
NAICS : 339113
SIC : 3842
ISIN : US28176E1082
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.29 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 0.38 | |||||
Interest Coverage | 102.74 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 10.67 | |||||
Beneish M-Score | -1.21 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.4 | |||||
3-Year EBITDA Growth Rate | 20.6 | |||||
3-Year EPS without NRI Growth Rate | 10.5 | |||||
3-Year FCF Growth Rate | 0.3 | |||||
3-Year Book Growth Rate | 14.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 99.83 | |||||
9-Day RSI | 97.07 | |||||
14-Day RSI | 91.06 | |||||
6-1 Month Momentum % | -14.36 | |||||
12-1 Month Momentum % | 9.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.46 | |||||
Quick Ratio | 2.89 | |||||
Cash Ratio | 2.29 | |||||
Days Inventory | 254.81 | |||||
Days Sales Outstanding | 42.33 | |||||
Days Payable | 44.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.3 | |||||
Shareholder Yield % | 3.4 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.97 | |||||
Operating Margin % | 27.4 | |||||
Net Margin % | 63.02 | |||||
FCF Margin % | 8.07 | |||||
ROE % | 55.59 | |||||
ROA % | 40.35 | |||||
ROIC % | 22.84 | |||||
ROC (Joel Greenblatt) % | 60.77 | |||||
ROCE % | 18.91 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 10.8 | |||||
Forward PE Ratio | 30.15 | |||||
PE Ratio without NRI | 28.02 | |||||
Shiller PE Ratio | 32.97 | |||||
Price-to-Owner-Earnings | 12.05 | |||||
PEG Ratio | 1.59 | |||||
PS Ratio | 6.85 | |||||
PB Ratio | 4.62 | |||||
Price-to-Tangible-Book | 6.32 | |||||
Price-to-Free-Cash-Flow | 91.79 | |||||
Price-to-Operating-Cash-Flow | 55.87 | |||||
EV-to-EBIT | 23.74 | |||||
EV-to-Forward-EBIT | 25.73 | |||||
EV-to-EBITDA | 21.82 | |||||
EV-to-Forward-EBITDA | 23.1 | |||||
EV-to-Revenue | 6.1 | |||||
EV-to-Forward-Revenue | 6.91 | |||||
EV-to-FCF | 82.53 | |||||
Price-to-Projected-FCF | 2.17 | |||||
Price-to-DCF (Earnings Based) | 1.11 | |||||
Price-to-DCF (FCF Based) | 6.95 | |||||
Price-to-Median-PS-Value | 0.76 | |||||
Price-to-Peter-Lynch-Fair-Value | 2 | |||||
Price-to-Graham-Number | 2.81 | |||||
Price-to-Net-Current-Asset-Value | 13.36 | |||||
Price-to-Net-Cash | 43.24 | |||||
Earnings Yield (Greenblatt) % | 4.21 | |||||
FCF Yield % | 1.12 | |||||
Forward Rate of Return (Yacktman) % | 15.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Edwards Lifesciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 117,433.953 | ||
EPS (TTM) (MXN) | 131.842 | ||
Beta | -0.04 | ||
Volatility % | 43.76 | ||
14-Day RSI | 91.06 | ||
14-Day ATR (MXN) | 6.790627 | ||
20-Day SMA (MXN) | 1434.7645 | ||
12-1 Month Momentum % | 9.39 | ||
52-Week Range (MXN) | 1129 - 1646.17 | ||
Shares Outstanding (Mil) | 589.8 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Edwards Lifesciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Edwards Lifesciences Corp Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Edwards Lifesciences Corp Frequently Asked Questions
What is Edwards Lifesciences Corp(MEX:EW)'s stock price today?
When is next earnings date of Edwards Lifesciences Corp(MEX:EW)?
Does Edwards Lifesciences Corp(MEX:EW) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |